{"id":961338,"date":"2026-05-12T07:35:12","date_gmt":"2026-05-12T11:35:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/"},"modified":"2026-05-12T07:35:12","modified_gmt":"2026-05-12T11:35:12","slug":"compass-therapeutics-to-participate-in-upcoming-may-investor-events-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/","title":{"rendered":"Compass Therapeutics to Participate in Upcoming May Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, May  12, 2026  (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of May.<\/p>\n<p align=\"left\">\n        <strong>Details are as follows:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ <\/strong><br \/>\n        <br \/>\n        <strong>Date:<\/strong> Tuesday, May 19, 2026 <br \/><strong>Time:<\/strong> 1:30 PM ET<br \/><strong>Webcast Link:<\/strong>\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hQkdpCsMJCzceS_rFSRRQUeZojyxoBc76XVkmgvFmF27Ug4oJbtLMbePNjlEUHaiHhiDkjjuRO2zGwEyW86JxF7NIEa32CNTpanAu9L_45Zz46VkP6FUY3AUTgHbzi7uhJKrPP_3MisSjbHhVzJlXoTDfCFfgz3MkqHxMycGW5n20KO375wKZ633R9UPhWvimCbl79DpH0kh7fbDAIJpMzvuHtUtxjr0v-18QheclrRrHRDZWrkpqZ2jFQaQnsHzUiyjIrzZNy-7fPA2Odd8Ew20eY2DswcfKo5r9EQphkMqKAVX11EQ06UtH60PjydP_xkot39Xk0QNVkb4PbJIjfYRvtSdkxSSSnAg-03Is1U3asiFIpoXOxHWTaXxEhUUISA-xsj7UwytDqtBNkNMH_7z1wuxZJrPVfk92ckBxAi-HSH_wy9YTnxVnYUWFjVXdaqADDLaTleUuzv0WG1_19tsCER3Wwi2g9u257iSfGt1Unk-LkwRTUiiHCr3uT-scfBEKgBGMFPYr6ZeTEZKaPdrFdbr7MR3t99NX1KSD74KoSdv6DcyrVvd1lm_58JT3ayF7kGoQFvOcqGDT57SDPM9PVLltBSB-G9SfPPT89YaHqfOIXO09b-fkHdy9wQArCeQkVIsD-Q3t2u5-NIu2kBEwnIQqSRY3Rl7_bOaxLQlY8Zim4x_kH-dP1RYV5gNe7dwyhRVgKE9egc6t-rwH3gkSjeYkPnO5FTIHPT3fG8J22RrPakBkuR5eygb1D3Y\" rel=\"nofollow\" target=\"_blank\">https:\/\/journey.ct.events\/view\/bc55d2f9-d121-4f7d-8129-1f69f201bd7f<\/a><\/p>\n<p align=\"left\">\n        <strong>2026 Stifel Virtual Targeted Oncology Forum<\/strong><br \/>\n        <br \/>\n        <strong>Date:<\/strong> Wednesday, May 20, 2026 <br \/><strong>Time:<\/strong> 11:30 AM ET<br \/><strong>Webcast Link:<\/strong>\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hQkdpCsMJCzceS_rFSRRQcdKxTOIZS-m8YFfRUvT7Fh9iszWVv5eg8rHNM0ZgKQ0EtSfdnfOAGVBCWsgvfo7ShikZwhFe5gliO_6kesjBZO28VaLMyq7lW39u2taZGnNz698zkQjH3oocJh95eNOOf9oMvztsWeTKImJotZlXAFD7g6HPezH_DCRZuOxerajc2MysbGl2XtvqOQ4Olc316WMdfi0c3G0ntBxpZ-tqB8ZAC-7r4hBzp-HPLD2RJUCJWwp1WBjEtg68Vl9YIw1HbJBmnecOCTe9YQD273ZF8xavhImSs4g51GGNOwzPZ5I75MjWoSZq2y7DyytLvDaWMBBWfPfbwdLdNFbeHNRXp26Toek-1HK3XdBa9EyrU3OzVMKdK7eAw1hyR0hyepzsGb2cbrv55jMvCVqxEnlJJeqHsoaE56VGh7VW3GhbpOATFRIDT3bk1XMZl7Ey4L-B1Q7BVzlBU1_4OVYODXFkL7G8xH-Z4hEhMcavcKXydlLwyACsqKCsfAv-wEOsoH9q9bPU8odzsfFp5Az0X3BDm_EofpUlRry18S6XS3oJsTpLOfJ7s03BgMM7GmnW0qedtssvDcLMx_fSZ5UIjcrGTzvtAjWul_pE853HIssfgv_JyPHAebvUkGiMjqVntzgPgH-l8wBq44QIs6oMv_sEVYSsFCAu6zupbq9uSD5bo6xh1qlHx8P9AdpRBxs7ydz8D0dxYwfms2g0OeURkJCsEWYwuJTLY56Llhs8MtudBZ-AOnUAZKGqHiB3Gp01B8dwaUEvloMsFRxrTQBhortZoU=\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.summitcast.com\/view\/SScpdhHfwE8g9WsS8WcTax\/QuhrzDf8Wdgui7i3FhuDb6<\/a><\/p>\n<p align=\"left\">\n        <strong>Virtual\/Replay availability:\u00a0<\/strong>Presentations will be archived on Compass\u2019\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DSh42Q7SsR9Zzb050-okgG1Rx4H-C1oEKMpyJlceN5eq_Bkyw5cXBmzuR0UK-Xw99BBgR0BeyHt4Z-R6_9gn2iDuzPQBoLmOFq5KW9w3NEW_efBHnVCEpr48y6BsZqV2gPnwvJUG7E7tgZNhwFe0sOOvhLSbh31sowUUXHDOX-HaEECTGVln1rz_UdrITbFkFmCmb-daHzeQlgGK5LW0k9qu5OTe_gkzxzmFq9yDzkhJwsz9zeQG8hbBK3nPyt3KYLSkbbvhfK0U6bCjU6aINclT5ExVKvD0_e61-MYZ5RbxDQO1GuZvMSXJTmPd4QxBXnS_swGaC9gjYSuIhntwbMG4FwXkJpBiGSli8GVsej9aI8hXQQLV9h3TaQNXeowKh_HIGwwWuZcFLj2ZcL5cb5QICEu4LQU_L5MuzpTkSk2EZjq0a6JKaWGYgPvGquC1J3VmyBX3Dly405z1qRvL-6L3Gn-kcu9e3oEH2i85GboAF4d0CqHe_bCID2N_Sdn-cEh1Kvbx4W0MnsrOzArFOJBbZ60Q2J0xZohI5j00TjRq1_0ladwy4iyeG7Vh8eKjFfD7XYVwnnlfHMRtksOWAq2J9FQkmfQ9ij2cTMspsGKWk791yYgETq62tQmUpEfXwvNWIM3hlF3iKukHHVVEfEgqMYubILD7AHjdm1BHfUPi_spSiPT7f7RX686sHbly9XsYv6-i5452HXeDse2JiMvbtPB2pybsOaXzuhCxRY0cyTMocVPjy9Bsptw-Ai1nHjeIsAymV-ZU6Mnbii_Qb-32bBMpLC1equH8CDZjgk3iKqLZYeX9iO8sy2b6Sss6eNk962l_vfHojvYJhisX1ftsqaLCz1o0AztYnxZur0sfwgggnqQZP7SnEU3Qm1_7M8s5J6jLK_GL64q-pPRc0rUVyBS1bPgfIEd_xI2SfOA4MEgfst3kpnRbVshZNiFsSkKE_BwPqz8-tUKq-jWWjVpwKVHyXAZDPsyNzvLmIfC1YDSVbTXZbesvjsUd3HNB3JCaX2W94Qb6XYgUzX8DluQJohZHX2Mxw5X1WqpYGonYynsnYU28hPZSulZA9A_xW4-Ql9NuXdpW68mEt3WxyLOtx64scHZBEYhNIU-X_GPAbcHdLtzeYHnQJEbNWtfeiB9Qtvh3qyJ1V8My-TVtyYijAX7pKCxsr-Q7cnxOJC9mm2ceHdG0QxIeLTlonryyEQDc-jpsqT-t9bvSh-7UrBeQppAD3Q6wFMbYbSItDJFJ9Vn0EQ8-iBGvIF9yxs4ExGp4SwlIw1c1zfJ177l3rB-a3pzkUHldKqrHxl8x4vILNJeXhh_EGRiksaDKz945w30v66_bGzCDUK_L9c-n_tXMMx8ggOYvfEg9MvNF2o3pJYxWxqnOjW668DsZoQQH0IcQnis5UcPRqpUjbE0cwnaXTgonJsGJ9dNHPgbaD0vtayCQIEhXhPs1-0E6Xn67mxiCCoXe-d4r7jajuTxlVWaNEysY8hSC8RfjV8t69wkCo-L-OlS9Y3DQUDmVBEFDZ103Ry0zaDVfJlTrZuwYNprCxURjQc1AAX_Ace9-f94HCKj5Utq912Wz-zaUUBwrMsXSHD9x7O0N06ULaK6DSA==\" rel=\"nofollow\" target=\"_blank\">Events<\/a><strong>\u00a0<\/strong>page.<\/p>\n<p align=\"left\">Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.<\/p>\n<p align=\"left\">\n        <strong>About Compass Therapeutics<\/strong><br \/>\n        <br \/>Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Boston, MA. Compass is a clinical-stage, oncology-focused biopharmaceutical company discovering and developing proprietary antibody-based therapeutics to treat multiple diseases. The company\u2019s scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. Compass has a robust pipeline of novel product candidates designed to target multiple key biological pathways to drive an effective anti-tumor response, including angiogenesis modulation, immune activation within the tumor microenvironment, and reduction of tumor-driven immunosuppression. The company is advancing discovery candidates through clinical development to commercial-stage assets. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SuScQFawC3oprPfGPqOoPH_dMQ8Ihyg1hx7wAtpJwfjfPRxFncRmDh_78YmmySt5jxEH6THmzvaQUoOY34RDH1YiuUB6MtnirPenZ6Q4q6oItYI0zLE3OZAZL7Kj1YQ5\" rel=\"nofollow\" target=\"_blank\">www.compasstherapeutics.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FIN9czxkc2HIxnEh7bYDNXeaf_xtscA3CqtKwieJexB702D03hwT9NNjM9b85Jzx43s_E2ynI5WMj2aa1zWh12vY-Hs7DqyfdFe0vW_pTiiIANXS1IiipxCtf5Yjx-ILBsJ9b8BQFUgzsDRk5gjuAfJkVMgPXUUnQknHCBYl7VBiDzQwF7IVsA8AwMVIjdrRyV2d8ztrSwEKbup2m1W68QDQmz1voFXNF9O11_eAbgblt6kbeW1mgJMTvRsclV0BOQ0vWnTam_4OTj91145oCL1irQ4C_FPDptSNr9rac-U=\" rel=\"nofollow\" target=\"_blank\">ir@compasstherapeutics.com<\/a>\n      <\/p>\n<p align=\"left\">\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Anna Gifford, Chief of Staff<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b2uDAMSxPEefN_tbj-mz4V8WCM4AjpAKIm2BJZ-m7Ou8EUJANCtuNvTtPVfv6hI3iq6omhuA7R29Mbq36F6_DrvcSWUO_SNuOdjoLKOEFQDHHpEBqmUays36GoE9McfZpCCFMedxG3vgNVfccIx63vD7pPyRQtWgNLOLzz0nQcACJP7g5kgm1BWBqPvXTRY-BAx3lNWlEYr1Rcxy05OXkuRl6I6IU9lkx-CiKNRbG7O9M6hs1jDDNCE6eIJ1wfwRBkyKpmkgc0AbIWIE5ENnNixUjt06rVfUH84kj6rfBEhROHlWFtjUM_IDGidze5eA\" rel=\"nofollow\" target=\"_blank\">media@compasstherapeutics.com<\/a><br \/>617-500-8099\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzFiMzAyMTUtYjBiNS00YjQ1LTgzMDAtYjAyZWJjZDMxMGIyLTEyMTM5NzUtMjAyNi0wNS0xMi1lbg==\/tiny\/Compass-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, May 12, 2026 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of May. Details are as follows: H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Date: Tuesday, May 19, 2026 Time: 1:30 PM ETWebcast Link:\u00a0https:\/\/journey.ct.events\/view\/bc55d2f9-d121-4f7d-8129-1f69f201bd7f 2026 Stifel Virtual Targeted Oncology Forum Date: Wednesday, May 20, 2026 Time: 11:30 AM ETWebcast Link:\u00a0https:\/\/event.summitcast.com\/view\/SScpdhHfwE8g9WsS8WcTax\/QuhrzDf8Wdgui7i3FhuDb6 Virtual\/Replay availability:\u00a0Presentations will be archived on Compass\u2019\u00a0Events\u00a0page. Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings. About Compass Therapeutics Compass Therapeutics, Inc. was founded in 2014 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Compass Therapeutics to Participate in Upcoming May Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-961338","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, May 12, 2026 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of May. Details are as follows: H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Date: Tuesday, May 19, 2026 Time: 1:30 PM ETWebcast Link:\u00a0https:\/\/journey.ct.events\/view\/bc55d2f9-d121-4f7d-8129-1f69f201bd7f 2026 Stifel Virtual Targeted Oncology Forum Date: Wednesday, May 20, 2026 Time: 11:30 AM ETWebcast Link:\u00a0https:\/\/event.summitcast.com\/view\/SScpdhHfwE8g9WsS8WcTax\/QuhrzDf8Wdgui7i3FhuDb6 Virtual\/Replay availability:\u00a0Presentations will be archived on Compass\u2019\u00a0Events\u00a0page. Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings. About Compass Therapeutics Compass Therapeutics, Inc. was founded in 2014 &hellip; Continue reading &quot;Compass Therapeutics to Participate in Upcoming May Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-12T11:35:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Participate in Upcoming May Investor Events\",\"datePublished\":\"2026-05-12T11:35:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/\",\"name\":\"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=\",\"datePublished\":\"2026-05-12T11:35:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Participate in Upcoming May Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk","og_description":"BOSTON, May 12, 2026 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of May. Details are as follows: H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Date: Tuesday, May 19, 2026 Time: 1:30 PM ETWebcast Link:\u00a0https:\/\/journey.ct.events\/view\/bc55d2f9-d121-4f7d-8129-1f69f201bd7f 2026 Stifel Virtual Targeted Oncology Forum Date: Wednesday, May 20, 2026 Time: 11:30 AM ETWebcast Link:\u00a0https:\/\/event.summitcast.com\/view\/SScpdhHfwE8g9WsS8WcTax\/QuhrzDf8Wdgui7i3FhuDb6 Virtual\/Replay availability:\u00a0Presentations will be archived on Compass\u2019\u00a0Events\u00a0page. Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings. About Compass Therapeutics Compass Therapeutics, Inc. was founded in 2014 &hellip; Continue reading \"Compass Therapeutics to Participate in Upcoming May Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-12T11:35:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Participate in Upcoming May Investor Events","datePublished":"2026-05-12T11:35:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/","name":"Compass Therapeutics to Participate in Upcoming May Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=","datePublished":"2026-05-12T11:35:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNzUzMSM3NTk1NzQyIzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-may-investor-events-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Participate in Upcoming May Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/961338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=961338"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/961338\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=961338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=961338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=961338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}